http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-265536-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3f69c520a3e508a423776b72b7f33fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6742624a360ed039e40e6376cc062ffc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b42313826798cfcf968de2fa4cbea8e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d31a4c994278e761ec10b063e310f22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba9d7d67b03013960821df9c3bf6495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 |
| filingDate | 1987-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e1f62fb0cb878d76b0a0fb7740136d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5f88a2713b76726359f927286f765a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4fab5876b15830b2cbaaf77ac24ba25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77d23075645363e6307ef322f43f7ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1035ec56252fc79b4c3f74d3d05f8274 |
| publicationDate | 1989-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CS-265536-B1 |
| titleOfInvention | Subunit vaccine against recurrent herpes and a method for its preparation |
| abstract | Subunit recurrent vaccinenHerpes is intended for immunotherapy of infectionsncaused by herpes simplex virus HS type 1.nThe vaccine contains specific glycoproteinsnespecially GB and BC from herpes simplex virus HSntype 1 strain HSZP, preferably from strain IV SASn02 to 60 and cell proteins from cellsngerms of Japanese quails with activityn2 to 20 antigen units per 1 h of protein.nThe method of preparation is that it is primoculturengerms of Japanese quails afterninfecting the HSZP virus strainnherpes simplex HS type 1, preferably strainnIV SAS 02-60. Infected cells are incubatednat 36.5 to 37.5 ° C for 18 ton22 hours, they look hypotonicna solution containing a non-ionic detergentnand the nucleocapsids are removed. Cell extractnit is inactivated by formaldehyde and finallynthe vaccine precipitates and purifies. |
| priorityDate | 1987-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.